Shanghai United Imaging Healthcare Co., Ltd. (688271.SS)
Full history for every metric is available with a Kvantra account
Shanghai United Imaging Healthcare Co., Ltd. (688271.SS)
No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNY bn | 6 | 7 | 9 | 11 | 10 | 14 | 15 | 17 |
| Operating profit | CNY bn | 2 | 2 | ||||||
| Net profit | CNY bn | 1 | 1 | 2 | 2 | 1 | 2 | 1 | 2 |
| EPS reported | CNY | 2.28 | 1.36 | ||||||
| Operating cashflow per share | CNY | 3.27 | 2.94 | ||||||
| Capex per share | CNY | 2.55 | 2.99 | ||||||
| FCF per share | CNY | 0.71 | -0.05 | ||||||
| Free cash flow | CNY bn | 1 | -0 | ||||||
| Net debt | CNY bn | -1 | -7 | ||||||
| Book value equity | CNY bn | 22 | 22 | ||||||
| Book value per share | CNY | 26.31 | 26.79 | ||||||
| Number of shares | m | 819.87 | 822.28 | ||||||
| DPS (TTM paid) | CNY | 0.21 | 0.26 |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 55.04 | 79.26 | ||||||
| P/B LTM | x | 4.77 | 4.67 | ||||||
| P/S LTM | x | 7.46 | 6.94 | ||||||
| P/FCF LTM | x | 175.64 | -2,399.93 | ||||||
| EV/EBITDA LTM | x | 40.63 | 44.33 | ||||||
| EV/Sales LTM | x | 7.49 | 5.75 | ||||||
| Earnings Yield LTM | % | +1.82% | +1.26% | ||||||
| FCF Yield | % | +0.57% | -0.04% | ||||||
| Quality | |||||||||
| ROE | % | +8.67% | +6.64% | ||||||
| ROIC | % | +7.60% | +6.32% | ||||||
| Operating margin | % | +14.49% | +12.67% | ||||||
| Gross margin | % | +47.01% | +32.83% | ||||||
| FCF/Sales | % | +4.25% | -0.29% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +48.05% | -11.69% | ||||||
| Sales Growth YoY | % | +33.98% | +44.04% | ||||||
| Net Income Growth YoY | % | +48.14% | -10.74% | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | +46.40% | +37.56% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +0.17% | +0.19% | ||||||
| Dividend Growth | % | -43.24% | -29.73% | ||||||
| Payout Ratio | % | +9.42% | +15.92% | ||||||
| FCF/Debt | x | 0.47 | -0.02 | ||||||
| Net Debt/EBITDA | x | 0.19 | -1.76 | ||||||
| EBIT/Net interest | x | 389.16 | 80.20 | ||||||
| Net debt/market cap | % | +0.92% | +2.50% | ||||||
| Net debt/Equity | x | -0.03 | -0.34 | ||||||
| Gross debt/equity | x | 0.06 | 0.08 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Shanghai United Imaging Healthcare Co., Ltd. engages in the provision, development, and production of advanced medical imaging solutions, radiotherapy equipment, life science instruments, and intelligent digital solutions worldwide. The company provides molecular imaging products; and magnetic resonance imaging solutions. It also offers computed tomography equipment; digital radiography equipment; mammography equipment; angiography equipment; mobile C-arm equipment; and radiotherapy systems comprising uRT-linac 506c, uRT-linac 306, and Intelligent RT Cloud Ecosystem. In addition, it provides uVision, a remote vision system that enables real-time positioning observation and automatic field of view identification; a low-dose, 3D mammography platform; and Remote Vision and Exposure Control technology application, a handheld X-ray from UIH that enables accurate positioning while reducing exposure radiation. Further, the company offers United Neuro, a medical imaging software used to analyze functional magnetic resonance imaging and diffusion tensor imaging data, and U-VIEWER, software that helps in viewing DICOM images. Additionally, it provides training, monitoring, maintenance, and troubleshooting services. Shanghai United Imaging Healthcare Co., Ltd. was founded in 2011 and is headquartered in Shanghai, China.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Shanghai United Imaging Healthcare Co., Ltd. (688271.SS)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Shanghai United Imaging Healthcare Co., Ltd. engages in the provision, development, and production of advanced medical imaging solutions, radiotherapy equipment, life science instruments, and intelligent digital solutions worldwide. The company provides molecular imaging products; and magnetic resonance imaging solutions. It also offers computed tomography equipment; digital radiography equipment; mammography equipment; angiography equipment; mobile C-arm equipment; and radiotherapy systems comprising uRT-linac 506c, uRT-linac 306, and Intelligent RT Cloud Ecosystem. In addition, it provides uVision, a remote vision system that enables real-time positioning observation and automatic field of view identification; a low-dose, 3D mammography platform; and Remote Vision and Exposure Control technology application, a handheld X-ray from UIH that enables accurate positioning while reducing exposure radiation. Further, the company offers United Neuro, a medical imaging software used to analyze functional magnetic resonance imaging and diffusion tensor imaging data, and U-VIEWER, software that helps in viewing DICOM images. Additionally, it provides training, monitoring, maintenance, and troubleshooting services. Shanghai United Imaging Healthcare Co., Ltd. was founded in 2011 and is headquartered in Shanghai, China.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free